Quadria Capital: A Leading Private Equity Firm

Author

Reads 3.8K

Close-Up View of Logo With Horse
Credit: pexels.com, Close-Up View of Logo With Horse

Quadria Capital is a leading private equity firm with a strong presence in Asia.

Founded in 2010, Quadria Capital has a proven track record of investing in the healthcare sector.

The firm has a unique investment approach that focuses on partnering with local management teams to drive growth and value creation.

Quadria Capital has invested in several successful healthcare companies across Asia, including Indonesia and Malaysia.

See what others are reading: Is Bain Capital a Private Equity Firm

About Quadria Capital

Quadria Capital is a private equity firm that focuses on investing in the healthcare sector in growth markets. They have a team of experienced professionals with a strong track record of investing in the region.

Their investment strategy is centered around partnering with exceptional entrepreneurs and management teams to drive growth and create value in their portfolio companies. They have invested in companies across various healthcare segments, including pharmaceuticals, medical devices, and healthcare services.

Quadria Capital has a strong presence in Asia, with offices in Singapore and Jakarta, and has invested in companies across the region. They have a deep understanding of the local markets and are well-positioned to identify opportunities for growth and value creation.

You might enjoy: Thoma Bravo Growth

Investments

Free stock photo of achievement, agreement, angel investor
Credit: pexels.com, Free stock photo of achievement, agreement, angel investor

Quadria Capital has made 21 investments, with their latest investment being in Aragen as part of their Private Equity - II on January 13, 2025. This investment was worth $100M.

Their investment portfolio includes companies such as NephroPlus, which they invested in for $101.81M in May 2024, and MediBuddy, which they invested in for $18M in August 2023.

Here are some of their notable investments:

Approach, Initiative, or Process

Quadria Capital manages over US$3.5 billion in assets, investing in the rapidly growing economies of South Asia and Southeast Asia.

Their approach to healthcare investing is guided by a principle that access to quality, affordable healthcare is a fundamental human right.

Quadria focuses on healthcare-driven businesses, providing capital, expertise, and networks to generate measurable impact in areas like accessibility, affordability, quality, and awareness.

Their investment strategy emphasizes stakeholder benefits and transformative healthcare solutions, with decisions guided by a robust impact thesis and scorecard.

Free stock photo of agreement, alliance, angel investor
Credit: pexels.com, Free stock photo of agreement, alliance, angel investor

The firm has a three-tiered strategy to ESG and impact, which was enhanced in 2023 with the introduction of an Impact Management and Measurement (IMM) framework.

The IMM framework integrates ESG and impact factors into investments, aligning with the UN SDGs and using metrics like key performance indicators (KPIs) and scorecards to measure performance outcomes.

Quadria integrates ESG analysis through detailed materiality studies and third-party due diligence, identifying risks and opportunities that align with stakeholder expectations and international ESG frameworks.

Their portfolio partners are expected to execute agreed ESG and/or impact action items within a stipulated timeframe, with performance outcomes and impact continuously monitored and tracked throughout the investment period.

Investments

Quadria Capital has made 21 investments, with their latest being in Aragen as part of their Private Equity - II on January 13, 2025.

Their investments have been spread across various companies, including NephroPlus, MediBuddy, and AKUMS Drugs & Pharmaceuticals. Quadria Capital's fund size is over $1 billion, and they expect Asia's healthcare market to reach $4.2 trillion within the next five years.

A contemplative businessman sitting at a meeting table in a modern office setting.
Credit: pexels.com, A contemplative businessman sitting at a meeting table in a modern office setting.

One of their notable investments was in NephroPlus, a company they invested in for $101.81 million in 2024. They also invested in MediBuddy, a company that received $18 million in Series C - II funding from Quadria Capital in 2023.

Here's a breakdown of some of their notable investments:

Quadria Capital's investments have been focused on the Asian healthcare market, which is expected to grow significantly in the coming years. They plan to put their capital to work over an eight-year period, with an extension of up to 10 years.

Portfolio Exits

Quadria Capital has a track record of successful portfolio exits, with a total of 5 exits to date.

Their latest exit was Akums Drugs, which went public on August 6, 2024, with a valuation of $XXM.

This is not an isolated incident, as Quadria Capital has a history of helping companies go public, with another IPO exit on August 18, 2023.

Business meeting with professionals discussing financial reports and graphs at a work desk.
Credit: pexels.com, Business meeting with professionals discussing financial reports and graphs at a work desk.

While the details of their earlier exits are not publicly available, we do know that they have experience with acquisitions, having facilitated an acquisition on July 11, 2023.

Here is a summary of Quadria Capital's portfolio exits:

3 Acquisitions

Quadria Capital has made three notable acquisitions. Their latest acquisition was Straits Orthopaedics on April 28, 2023, with a valuation of $XXM.

The company's acquisition history is not entirely publicly available, as two of the acquisitions are hidden behind a subscription paywall.

However, we do know that one of the acquisitions was made on December 20, 2013, although the company name and valuation are not disclosed.

Here are the details of Quadria Capital's three acquisitions:

Fund History

Quadria Capital has a rich history of managing funds, with a total of 10 funds under their management. One of their notable funds is the Quadria Capital Asia Healthcare Fund III, which closed on December 6, 2024, with a massive amount of $800 million.

Related reading: What Are Capital Funds

Detailed close-up of gold bars and coins symbolizing wealth and investment opportunities.
Credit: pexels.com, Detailed close-up of gold bars and coins symbolizing wealth and investment opportunities.

The fund was established to invest in the healthcare sector in Asia, and its closing date and amount are publicly available. In contrast, the Quadria Capital Fund III closed on October 18, 2023, with a significantly lower amount of $525 million.

Quadria Capital Fund II PAR was established on March 11, 2020, and it had a relatively modest amount of $52.2 million. Unfortunately, the fund type and status of this fund are not publicly available due to subscription requirements.

The closing dates of Quadria Capital's funds are as follows:

The amounts of Quadria Capital's funds are also publicly available, with the Quadria Capital Asia Healthcare Fund III having the largest amount of $800 million.

Partners and Team

Quadria Capital is a global investment firm with a strong team and network of partners. Their team has a deep understanding of the healthcare and education sectors, which is reflected in their investment strategies.

The firm's partners have a diverse range of experience, with backgrounds in private equity, venture capital, and operating roles. They work closely with each other and with their portfolio companies to drive growth and success.

Quadria Capital's team is based in several locations around the world, including Singapore, Hong Kong, and the US. This global presence allows them to stay connected with their portfolio companies and identify new investment opportunities.

Partners & Customers

Smiling businessman in office analyzing financial graphs on a large screen, demonstrating professional success.
Credit: pexels.com, Smiling businessman in office analyzing financial graphs on a large screen, demonstrating professional success.

Quadria Capital has a strong network of partners and customers that help drive its growth and success. One of its key partners is Strand Life Sciences, a company it partnered with on February 2, 2018.

Strand Life Sciences is an Indian company that has benefited from Quadria Capital's expertise in building healthcare businesses in Asia. In fact, the partnership helped Strand Life Sciences launch into its next phase of growth and into an era where data analytics and molecular measurements change diagnosis and treatment paradigms.

Quadria Capital also partnered with SOHO Global Health in Indonesia on January 27, 2015. This partnership is a testament to the company's ability to build relationships with businesses across different regions.

Here are the key partners and customers of Quadria Capital:

Team

Our team at Quadria Capital is comprised of 11 dedicated individuals, including Sunil Thakur, who currently serves as the Chief Operating Officer and Managing Director.

Frequently Asked Questions

What is the ticket size for Quadria Capital?

Quadria Capital's new fund has a ticket size of up to $75 million. This represents an increase from their previous fund size.

What is Quadria Capital AUM?

Quadria Capital manages around $3.3-4 billion in assets globally. Their AUM in India is approximately $1 billion.

Tasha Schumm

Junior Writer

Tasha Schumm is a skilled writer with a passion for simplifying complex topics. With a focus on corporate taxation, business taxes, and related subjects, Tasha has established herself as a knowledgeable and engaging voice in the industry. Her articles cover a range of topics, from in-depth explanations of corporate taxation in the United States to informative lists and definitions of key business terms.

Love What You Read? Stay Updated!

Join our community for insights, tips, and more.